Caris Life Sciences, Inc. Common Stock CAI
$16.49
-4.57%
at last close
Financials (TTM)
- Revenue
- $907.29 million
- Net Income
- $33.98 million
- Net Margin
- 3.75%
- Return on Equity
- 5.73%
- Debt-to-Equity
- 0.64
- P/E Ratio
- —
- Price / Book
- 7.85
- Price / Sales
- 5.14
Over the trailing twelve months, Caris Life Sciences, Inc. Common Stock generated revenue of $907.29 million and net income of $33.98 million, a net margin of 3.75%.
At the last closing price of $16.49, CAI trades at 5.14 times sales, with a market capitalization of $4.66 billion.
Key Stats
- Last Close
- $16.49
- Market Cap
- $4.66 billion
- 52-Week Range
- $14.19 – $42.50
- Average Volume
- 2.91 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.